Halozyme Therapeutics Inc. (HALO) Stock Is Emerging from the Clouds

TD Cowen raised the price target for the Halozyme Therapeutics Inc. (NASDAQ:HALO) stock to “an Outperform”. The rating was released on February 29, 2024, according to finviz. The research report from Goldman has downgraded the stock from Buy to Neutral, with a price target set at $45. The stock was upgraded by Piper Sandler, who […]

Earnings and valuation of Halozyme Therapeutics Inc. (HALO) Stock are impressive

TD Cowen raised the price target for the Halozyme Therapeutics Inc. (NASDAQ:HALO) stock to “an Outperform”. The rating was released on February 29, 2024, according to finviz. The research report from Goldman has downgraded the stock from Buy to Neutral, with a price target set at $45. The stock was upgraded by Piper Sandler, who […]

What does the future hold for Halozyme Therapeutics Inc. (HALO) Stock?

TD Cowen raised the price target for the Halozyme Therapeutics Inc. (NASDAQ:HALO) stock to “an Outperform”. The rating was released on February 29, 2024, according to finviz. The research report from Goldman has downgraded the stock from Buy to Neutral, with a price target set at $45. The stock was upgraded by Piper Sandler, who […]